198 related articles for article (PubMed ID: 10570965)
1. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.
Schummer M; Ng WV; Bumgarner RE; Nelson PS; Schummer B; Bednarski DW; Hassell L; Baldwin RL; Karlan BY; Hood L
Gene; 1999 Oct; 238(2):375-85. PubMed ID: 10570965
[TBL] [Abstract][Full Text] [Related]
2. Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays.
Martoglio AM; Tom BD; Starkey M; Corps AN; Charnock-Jones DS; Smith SK
Mol Med; 2000 Sep; 6(9):750-65. PubMed ID: 11071270
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
[TBL] [Abstract][Full Text] [Related]
4. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
[TBL] [Abstract][Full Text] [Related]
5. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
6. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
[TBL] [Abstract][Full Text] [Related]
7. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray.
Wang K; Gan L; Jeffery E; Gayle M; Gown AM; Skelly M; Nelson PS; Ng WV; Schummer M; Hood L; Mulligan J
Gene; 1999 Mar; 229(1-2):101-8. PubMed ID: 10095109
[TBL] [Abstract][Full Text] [Related]
8. ELF5 in epithelial ovarian carcinoma tissues and biological behavior in ovarian carcinoma cells.
Yan H; Qiu L; Xie X; Yang H; Liu Y; Lin X; Huang H
Oncol Rep; 2017 Mar; 37(3):1412-1418. PubMed ID: 28184931
[TBL] [Abstract][Full Text] [Related]
9. Expression of angiopoietin-1, angiopoietin-2, and Tie2 genes in normal ovary with corpus luteum and in ovarian cancer.
Hata K; Udagawa J; Fujiwaki R; Nakayama K; Otani H; Miyazaki K
Oncology; 2002; 62(4):340-8. PubMed ID: 12138242
[TBL] [Abstract][Full Text] [Related]
10. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
[TBL] [Abstract][Full Text] [Related]
11. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
[TBL] [Abstract][Full Text] [Related]
12. Low expression of miR-449 in gynecologic clear cell carcinoma.
Jang SG; Yoo CW; Park SY; Kang S; Kim HK
Int J Gynecol Cancer; 2014 Nov; 24(9):1558-63. PubMed ID: 25238166
[TBL] [Abstract][Full Text] [Related]
13. Differential gene expression between normal and tumor-derived ovarian epithelial cells.
Ismail RS; Baldwin RL; Fang J; Browning D; Karlan BY; Gasson JC; Chang DD
Cancer Res; 2000 Dec; 60(23):6744-9. PubMed ID: 11118061
[TBL] [Abstract][Full Text] [Related]
14. Identification and comparison of gonadal transcripts of testis and ovary of adult common carp Cyprinus carpio using suppression subtractive hybridization.
Chen JJ; Xia XH; Wang LF; Jia YF; Nan P; Li L; Chang ZJ
Theriogenology; 2015 Jun; 83(9):1416-27. PubMed ID: 25772851
[TBL] [Abstract][Full Text] [Related]
15. Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expression.
Du F; Li Y; Zhang W; Kale SP; McFerrin H; Davenport I; Wang G; Skripnikova E; Li XL; Bowen NJ; McDaniels LB; Meng YX; Polk P; Liu YY; Zhang QJ
Tumour Biol; 2016 Aug; 37(8):11147-11162. PubMed ID: 26935058
[TBL] [Abstract][Full Text] [Related]
16. Loss of E-cadherin disrupts ovarian epithelial inclusion cyst formation and collective cell movement in ovarian cancer cells.
Choi PW; Yang J; Ng SK; Feltmate C; Muto MG; Hasselblatt K; Lafferty-Whyte K; JeBailey L; MacConaill L; Welch WR; Fong WP; Berkowitz RS; Ng SW
Oncotarget; 2016 Jan; 7(4):4110-21. PubMed ID: 26684027
[TBL] [Abstract][Full Text] [Related]
17. Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes.
Bourdon V; Naef F; Rao PH; Reuter V; Mok SC; Bosl GJ; Koul S; Murty VV; Kucherlapati RS; Chaganti RS
Cancer Res; 2002 Nov; 62(21):6218-23. PubMed ID: 12414650
[TBL] [Abstract][Full Text] [Related]
18. Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.
Gyftaki R; Liacos C; Politi E; Liontos M; Saltiki K; Papageorgiou T; Thomakos N; Haidopoulos D; Rodolakis A; Alevizaki M; Bamias A; Dimopoulos A
Int J Gynecol Cancer; 2014 Jun; 24(5):851-6. PubMed ID: 24844218
[TBL] [Abstract][Full Text] [Related]
19. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
20. Differential gene expression in ovarian carcinoma: identification of potential biomarkers.
Hibbs K; Skubitz KM; Pambuccian SE; Casey RC; Burleson KM; Oegema TR; Thiele JJ; Grindle SM; Bliss RL; Skubitz AP
Am J Pathol; 2004 Aug; 165(2):397-414. PubMed ID: 15277215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]